Details for Patent: 11,400,067
✉ Email this page to a colleague
Which drugs does patent 11,400,067 protect, and when does it expire?
Patent 11,400,067 protects AQNEURSA and is included in one NDA.
This patent has seventy-seven patent family members in thirty-three countries.
Summary for Patent: 11,400,067
| Title: | Pharmaceutical compositions and uses directed to lysosomal storage disorders |
| Abstract: | The present disclosure provides for treating lysosomal storage disorders (LSDs) comprising administering acetyl-leucine or a pharmaceutically acceptable salt thereof. |
| Inventor(s): | Michael Strupp |
| Assignee: | Intrabio Ltd |
| Application Number: | US16/324,301 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 11,400,067 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 11,400,067
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Intrabio | AQNEURSA | levacetylleucine | FOR SUSPENSION;ORAL | 219132-001 | Sep 24, 2024 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | USE OF LEVACETYLLEUCINE FOR TREATMENT OF NEUROLOGICAL MANIFESTATIONS OF NIEMANN-PICK DISEASE TYPE-C (NPC) | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,400,067
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 3482754 | ⤷ Start Trial | CA 2026 00020 | Denmark | ⤷ Start Trial |
| European Patent Office | 3482754 | ⤷ Start Trial | 301377 | Netherlands | ⤷ Start Trial |
| European Patent Office | 3482754 | ⤷ Start Trial | CR 2026 00020 | Denmark | ⤷ Start Trial |
| European Patent Office | 3482754 | ⤷ Start Trial | C20260014 | Finland | ⤷ Start Trial |
| European Patent Office | 3482754 | ⤷ Start Trial | PA2026517 | Lithuania | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
